Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02194595
What this trial is testing

Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)

Who this might be right for
Type 2 Diabetes
Mount Sinai Hospital, Canada 105
Not applicableStudy completedNCT01281228
What this trial is testing

The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2Obesity
Amsterdam UMC, location VUmc 48
Testing effectiveness (Phase 2)Study completedNCT00822705
What this trial is testing

Inhibition of Food Intake in Response to Oral GLP-1 and Peptide YY3-36

Who this might be right for
Anti Obesity Agent
University Hospital, Basel, Switzerland 16
Early research (Phase 1)Study completedNCT01449019
What this trial is testing

The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Diabetes Mellitus, Type 2
Ludwig-Maximilians - University of Munich 24
Large-scale testing (Phase 3)Study completedNCT05205928
What this trial is testing

Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care

Who this might be right for
Type 1 DiabetesDiabetes Mellitus, Type 1
McGill University Health Centre/Research Institute of the McGill University Health Centre 28
Post-approval studies (Phase 4)Active Not RecruitingNCT06803888
What this trial is testing

Bariatric Surgery vs. Semaglutide vs. Tirzepatide

Who this might be right for
Obesity and Obesity-related Medical Conditions
Ali Aminian 140
Not applicableUnknownNCT01176708
What this trial is testing

Intact Liver Innervation and Glucose and Glucagon-like Peptide-1 (GLP-1) Induced Insulin Secretion

Who this might be right for
Liver Transplantation
University Hospital, Gentofte, Copenhagen 30
Not applicableStudy completedNCT06408610
What this trial is testing

Moderate Continuous Versus High Interval Intensity Training on Gut Dysbiosis and GLP1 Hormone in IBS

Who this might be right for
Irritable Bowel SyndromeObesityDysbiosis
Cairo University 66
Not applicableStudy completedNCT07240246
What this trial is testing

Effect of a Dietary Supplement on Hormones Involved in Appetite Regulation in Overweight and Obese Adults

Who this might be right for
GLP-1Obesity &Amp; OverweightDietary Supplement
FFoQSI - Austrian Competence Centre for Feed and Food Quality, Safety & Innovation 40
Post-approval studies (Phase 4)Looking for participantsNCT07178145
What this trial is testing

Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction

Who this might be right for
Heart Failure Preserved Ejection FractionEpicardial Adipose Tissue
University of Virginia 192
Large-scale testing (Phase 3)Looking for participantsNCT07387094
What this trial is testing

XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy

Who this might be right for
OSA - Obstructive Sleep ApneaObesity
Hangzhou Sciwind Biosciences Co., Ltd. 140
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07747805
What this trial is testing

GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD

Who this might be right for
COPDObesity & OverweightSarcopenia
The Cleveland Clinic 30
Post-approval studies (Phase 4)UnknownNCT04029272
What this trial is testing

Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients

Who this might be right for
Polycystic Ovary Syndrome
Peking Union Medical College Hospital 80
Post-approval studies (Phase 4)Looking for participantsNCT07111494
What this trial is testing

Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial

Who this might be right for
Psoriatic Arthritis (PsA)
Medical College of Wisconsin 22
Very early researchLooking for participantsNCT06751589
What this trial is testing

A Weight Loss Intervention in People With Endometrial Cancer

Who this might be right for
Endometrial Cancer
Memorial Sloan Kettering Cancer Center 36
Testing effectiveness (Phase 2)Looking for participantsNCT06924320
What this trial is testing

MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes

Who this might be right for
Obesity and Obesity-related Medical Conditions
Pfizer 381
Not applicableLooking for participantsNCT06318442
What this trial is testing

The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes

Who this might be right for
Steroid-Induced DiabetesSteroid Induced Hyperglycemia
Imperial College London 60
Post-approval studies (Phase 4)Looking for participantsNCT07163650
What this trial is testing

Evaluating Anti-Obesity Medications 6 Months After Metabolic Surgery

Who this might be right for
ObesityWeight LossMetabolic Surgery
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 60
Testing effectiveness (Phase 2)Study completedNCT01800968
What this trial is testing

Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)

Who this might be right for
Acute Heart Failure
Duke University 300
Not applicableStudy completedNCT01561235
What this trial is testing

Protein Dose-repsonse Effect on GLP-1, PYY and Appetite in Male Subjects

Who this might be right for
Obesity
University of Copenhagen 25
Next Page